Literature DB >> 7639684

Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2.

S Saneshige1, H Mano, K Tezuka, S Kakudo, Y Mori, Y Honda, A Itabashi, T Yamada, K Miyata, Y Hakeda.   

Abstract

Vitamin A metabolites such as all-trans-retinoic acid (all-trans-RA) affect several steps of metabolic processes in vertebrates. In the last few years, several studies have shown the effect of RA on bone formation and metabolism. However, mechanisms of its action still remain unclear, especially with respect to the regulation of bone cells. Therefore, this study was carried out to clarify how RA regulates the activity of osteoclasts. Using a pit assay involving unfractionated bone cells, including osteoclasts obtained from rabbits, we found that RA stimulated an increase in the bone-resorbing activity in a dose- and time-dependent manner. Furthermore, this effect occurred more rapidly than that of treatments with 1 alpha,25-dihydroxyvitamin D3. However, this effect of RA may be partly related to cross-talk between osteoclasts and other types of cells. Therefore we studied the effect of RA on isolated osteoclasts. We found that all-trans-RA regulates the gene expression of cathepsin K/OC-2, a dominant cysteine proteinase, at the transcriptional level in mature osteoclasts isolated from rabbits. Moreover, retinoic acid-receptor alpha mRNA and retinoid X-receptor beta mRNA were expressed in these mature osteoclasts. Our results indicate that osteoclasts are target cells for RA and that RA might regulate a part of bone formation and metabolism through osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639684      PMCID: PMC1135691          DOI: 10.1042/bj3090721

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Activity of vitamin A analogues in cell cultures of mouse epidermis and organ cultures of hamster trachea.

Authors:  M B Sporn; G H Clamon; N M Dunlop; D L Newton; J M Smith; U Saffiotti
Journal:  Nature       Date:  1975-01-03       Impact factor: 49.962

Review 2.  A human retinoic acid receptor which belongs to the family of nuclear receptors.

Authors:  M Petkovich; N J Brand; A Krust; P Chambon
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

3.  Pathogenesis of the optic nerve lesion in vitamin A-deficient calves.

Authors:  K C Hayes; S W Nielsen; H D Eaton
Journal:  Arch Ophthalmol       Date:  1968-12

4.  Stimulation of differentiation of several murine embryonal carcinoma cell lines by retinoic acid.

Authors:  A M Jetten; M E Jetten; M I Sherman
Journal:  Exp Cell Res       Date:  1979-12       Impact factor: 3.905

5.  Effect of retinoids on the growth, ultrastructure, and cytoskeletal structures of malignant rat osteoblasts.

Authors:  K W Ng; S A Livesey; F Collier; P R Gummer; T J Martin
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

6.  1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.

Authors:  P M McSheehy; T J Chambers
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  Effects of hypervitaminosis A on the bone and mineral metabolism of the rat.

Authors:  S Hough; L V Avioli; H Muir; D Gelderblom; G Jenkins; H Kurasi; E Slatopolsky; M A Bergfeld; S L Teitelbaum
Journal:  Endocrinology       Date:  1988-06       Impact factor: 4.736

8.  Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures.

Authors:  B R MacDonald; N Takahashi; L M McManus; J Holahan; G R Mundy; G D Roodman
Journal:  Endocrinology       Date:  1987-06       Impact factor: 4.736

9.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants.

Authors:  D Lohnes; M Mark; C Mendelsohn; P Dollé; A Dierich; P Gorry; A Gansmuller; P Chambon
Journal:  Development       Date:  1994-10       Impact factor: 6.868

View more
  16 in total

1.  Estrogen directly down-regulates the bone-resorbing activity of mature osteoclasts through nuclear estrogen receptor alpha.

Authors:  H Mano; Y Hakeda; M Kumegawa
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

Review 2.  Minireview: nuclear receptor regulation of osteoclast and bone remodeling.

Authors:  Zixue Jin; Xiaoxiao Li; Yihong Wan
Journal:  Mol Endocrinol       Date:  2014-12-30

3.  Protease-Activated Receptor 1 Deletion Causes Enhanced Osteoclastogenesis in Response to Inflammatory Signals through a Notch2-Dependent Mechanism.

Authors:  Sandra Jastrzebski; Judith Kalinowski; Sehwan Mun; Bongjin Shin; Naga Suresh Adapala; Christian E Jacome-Galarza; Faryal Mirza; H Leonardo Aguila; Hicham Drissi; Archana Sanjay; Ernesto Canalis; Sun-Kyeong Lee; Joseph A Lorenzo
Journal:  J Immunol       Date:  2019-05-20       Impact factor: 5.422

4.  Retinoic acid inhibits NFATc1 expression and osteoclast differentiation.

Authors:  Wayne Balkan; María Rodríguez-Gonzalez; Manhui Pang; Isabel Fernandez; Bruce R Troen
Journal:  J Bone Miner Metab       Date:  2011-03-08       Impact factor: 2.626

5.  Expression of MT1-MMP during deciduous tooth resorption in odontoclasts.

Authors:  Busayarat Linsuwanont-Santiwong; Yuzo Takagi; Keiichi Ohya; Hitoyata Shimokawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

6.  Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK.

Authors:  Lijuan Hu; Thomas Lind; Anders Sundqvist; Annica Jacobson; Håkan Melhus
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

Review 7.  Natural medicine delivery from biomedical devices to treat bone disorders: A review.

Authors:  Susmita Bose; Naboneeta Sarkar; Dishary Banerjee
Journal:  Acta Biomater       Date:  2021-02-28       Impact factor: 8.947

8.  Deficiency of retinaldehyde dehydrogenase 1 induces BMP2 and increases bone mass in vivo.

Authors:  Shriram Nallamshetty; Hong Wang; Eun-Jung Rhee; Florian W Kiefer; Jonathan D Brown; Sutada Lotinun; Phuong Le; Roland Baron; Clifford J Rosen; Jorge Plutzky
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

9.  Heterodimeric BMP-2/7 antagonizes the inhibition of all-trans retinoic acid and promotes the osteoblastogenesis.

Authors:  Wenjuan Bi; Zhiyuan Gu; Yuanna Zheng; Xiao Zhang; Jing Guo; Gang Wu
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

10.  Hypervitaminosis A is prevalent in children with CKD and contributes to hypercalcemia.

Authors:  Baheerathi Manickavasagar; Andrew J McArdle; Pallavi Yadav; Vanessa Shaw; Marjorie Dixon; Rune Blomhoff; Graeme O' Connor; Lesley Rees; Sarah Ledermann; William Van't Hoff; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2014-08-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.